Background: Th e study was conducted to see the association of cervical abnormalities in relation to high risk Human Papilloma Virus (HR-HPV) infection at King Hamad University Hospital, Bahrain. Materials and Methods: It was a retrospective cohort study completed in 3 years at King Hamad University Hospital, Department Pathology Lab and other private Hospitals of Bahrain. Patients of Obstetrics and Gynecology out patient's clinic and other requesting private hospitals were included in this study.A non-probability purposive sampling technique was used for this retrospective review of 160pathology reports and HPV cervista reports. Data was collected from I-Seha and patients Al-care, and was transferred and assessed SPSS-version 22. Results: Th ere were 160 cases in total, who were examined for HPV-HR DNA using Cervista molecular testing. Th ere were 73 cases were Positive for HPV and 87 cases negative for HPV. Th e minimum age of patiesnt's was 20 years while the max was 70 years. Th e mean age was 42.5 years. HR-HPV was detected in (100%) all cervical HSIL cases and in 71% of LSIL cases. Cervical intraepithelial lesion CIN2/3+ was signifi cantly associated with HR-HPV positive cases. Compared to HPV positive cases, here was no cervical intraepithelial lesion (CIN) of any grade found in HR_HPV negative cases. Th ere were only four cases with LSIL found to be R-HPV positive, which may be associated with Low-risk HPV infection. Conclusion: Th ere was strongest association of cervical neoplastic lesions with high risk HPV to control.
premalignant and malignant conditions. It is included in the screening program for evaluation of all patients with abnormal cervical smears in developed countries. This test is adopted because it is a simple and cost-eff ective technique for the detection of early changes in the cervical epithelium. Unfortunately, many developing countries lack the ability to carry out widespread Pap screening.
INTRODUCTION
Cervical cancer is still the commonest malignancy among female, with 528,000 new cases and 266,000 deaths each year worldwide. 1 For the eff ective screening method of cervical lesions, the Papanicolaou cervical cytology is used to detect necessary for the development of cervical cancer and its precancerous lesion. Epidemiologic case series have shown that nearly 100% of cervical cancer cases, test positive for HPV. According to Bethesda system 2012, HPV-related squamous intraepithelial lesions(SIL) which is diagnosed by PAP test cytology are divided into the low squamous intraepithelial lesion (LSIL) encompasses the histological diagnosis of cervical intraepithelial neoplasms 1 (CIN1), and High grade squamous intraepithelial lesion (HSIL) encompasses cervical intraepithelial neoplasia (CIN2 and CIN3). 7 Many techniques have been introduced to detect DNA and RNA in high risk HPV infected cells. The most popular techniques, are DNA amplifi cation using Hybrid capture 2, Real time Polymerase chain Reaction using cobas HPV test and GeneXpert,a messenger RNA detection technique using Aptima HPV assay,and Signal amliphication Invader technology using Cervista test. The study was conducted to detect high risk HPV using Invader molecular technology and to see any association of diff erent known risk factors for neoplastic (premalignant and malignant) cervical Lesions.
MATERIALS AND METHODS

Study Design
It was retrospective cohort study.
Study Universe and Study Population
Sample size was calculated according to the prevalence of HPV and 160 cases were selected out of 7500 Papanicolaou (Pap) smears of cervical cytology, who attended the Gynecology Clinics of King Hamad University Hospital Bahrain,and other requesting private hospitals from October 2012 to October 2014.
Data Collection
Cases of cervical abnormalities were selected according to the Bethesda System. 2 These cases of cervical lesions were followed for biopsy (punch biopsy, conization and hysterectomies).
The study was conducted according to the standardized protocol of the International Agency for Research on Cancer (IARC) HPV Prevalence Surveys. 8 Ethical approval of ethical principles for medical research for human subjects for the study was received from the Review board of ethical commi ee of the University, Bahrain. 
Inclusion Criteria
Diagnostic criteria
Papanicolaou tests for all patients were evaluated using manual cytotechnologist review. Papanicolaou tests suspicious for reactive, reparative, or dysplastic changes were reviewed by competent anatomic pathologists. Cytologic fi ndings were classifi ed according to the 2001 Bethesda System terminology for reporting results of cervical cytology. Abnormal cytological lesions were followed by histopathology cervical biopsy, and cervical conization by loop electrosurgical excision procedure (LEEP).
All HR-HPV DNA testing was performed on patients following ACS, SCCP, ASCP, 2012 Guidelines where in sensitivity, specifi city, positive predictive value, negative predictive value, false positive rate, and false negative rate were calculated by defi nition. The chi-square test was performed for comparative analysis and the results were considered statistically signifi cant at p-values <0.05. Fisher exact test was used to determine the statistical signifi cance of the diff erence.
RESULTS
There were 160 cases in total, who were examined for HPV-HR DNA using Cervista molecular testing.The minimum age of patients was 20 years while the max was 70 years. The mean age was 42.5 years. There were 73 cases Positive for HPV and 87 cases negative for HPV. There were 23 (31%) Bahraini women out of 73(46%) women with positive high risk HPV. The second most common females were of Philippines women, then Indian and British women comprising of 15 (21%), 07 (10%) and 05 (7%) respectively.
Out of 73 (46%) HPV positive cases, 17(23%) cases were normal showing no cytology problems. 28 (38%) cases were ASCUS. 10 (17%)cases were LSIL, 13 (18%) cases were HSIL, 2 (3%)cases were ASC-H and one cases (1%) was AGC. (Table 1) On histology follow up, out of 73 cases with positive HPV result, 30 cases have histopathology follow up (41%). From the 30 cases, 5 cases were normal (17%), 8 cases showed koilocytic changes (27%), 6 cases showed CIN1) 20%, 2 cases showed (CINII) (7%), 8 cases showed (CINIII) 27% and I cases showed unsatisfactory result (3.3%). HR-HPV was detected in all cervical HSIL cases and in 71% of LSIL cases. Cervical intraepithelial lesion CIN2/3+ was signifi cantly associated with HR_HPV positive cases (Tables 1 and 2 and Figures 1-3 ).
Compared to HPV positive cases, 87 cases (54%) were HPV negative. Out of 87 cases 57 cases were normal (66%), patients with atypical squamous cells of undetermined signifi cance (ASCUS) cervical cytology results are tested for HPV to determine the need for referral to colposcopy. HPV is also tested in women 30 years and older as a co-testing with cervical cytology to adjunctively screen to assess the presence or absence of high-risk HPV.
Results were categorized as either Cervista HPV HR negative or Cervista HPV HR positive based on Carboxyfl uorescein dye (FAM) fluorescent signal that lies either above an empirically derived cut-off value or below it. For each reaction, a positive result is represented by a FAMfl uorescent signal that lies above an empirically derived cut-off value. (cervista).
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Statistical Analysis Data was entered and analyzed through SPSS version 16 by researcher herself. Quantitative variable like age was presented in form of mean ± SD with respect to type of cancer and year. The qualitative variables like gender, type of cancer etc., were presented in form of frequency tables and appropriate charts.
Simple percentage of the positive lesions was calculated and compared with histopathology reports. The accuracy rate, showing no cytological or histopathological problems. The ASCUS was seen in 22 (25%) cases. Only 4 cases (5%) were with low-grade abnormalities (LSIL).
Confection with other STD was seen in 2 cases with history of herpes infection in HPV positive cases.
The relative risk was 2.3 (An RR of > 1 means the event was more likely to occur in the HPV Positive group than in the HPV negative group) ( Table 3) .
DISCUSSION
Cervical cancer is the 4th commonest female malignancy in the world. A wide range of regional diversity in the incidence of cervical cancer in diff erent parts of the world is evident from several reports.
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In Bahrain, there have been no studies showing the extent of the incidence of this virus in the community, perhaps because cervical cancer is not frequently seen in the country. Unlike the rest of the world, cervical cancer is considered locally the eleventh most prevalent cancer among women. 12 In addition, a high prevalence of HPV was in more other women working in Bahrain (70%) as compared to the natives (30%). It was less seen in Bahraini population because HPV is considered to be a sexually transmi ed disease and Arab society is known to be a conservative one when it comes to adult sexuality, which is supposed to exist only after marriage.Among other non-Bahraini workingwomen Philippians were bearing more PHV infections and cervical abnormalities (21%) as compared to another and then comes Indians and British women which comprise 10% and 7% respectively.
We used Cervista techniquesfor the detection of this high risk HPV. Our study showed a relatively high prevalence of cervical abnormalities with HPV infection among women residing in Bahrain. For traditional reasons, only married, divorced, and widowed females were registered in this cohort study. All of them visited Gynecology Clinics of King Hamad University Hospital Bahrain, and other requesting private hospitals for routine and follow up gynecological examination. In this general screening, we found koilocytic lesions, ASCUS, AGS, LSIL and HSIL in our HPV positive and negative cases.
There were 160and minimum age of patients was 20 years while the max was 70 years. The mean age was 42.5 years. Abnormal cytology smears were followed by Histopathology.
In diff erent studies the age trends of cervical lesions seemed to high at a relatively younger age in North America (<30 years), compared with 25 to 40 years in Europe and Middle East, Africa, Asia, and Central and South America. Age pa erns of low-grade lesions generally declined after a peak in the younger age groups (20-30 years). 11 Our fi ndings shows that HPV prevalence is age dependent with the highest rate among women age 30-39 (42%)and the lowest rate among women age 50 and above (14%). Our fi ndings are inconsistent with Dunne et al, that shows decreasing in HPV prevalence among women age 50 and above to 39% (Dunne). However, the highest rate of HPV prevalence in Dunne study occurs among women age 20-24 which comprise 54% of total cases, while with our study, the highest rate occurs among women age 30-39. This can be due the conservative society of Muslims and Arabs when it comes to adult sexuality, which normally start after marriage and with the average age of 27.
In our study, HSIL is encountered in 8% of all cytology cases. HPV testing is not necessary for women with HSIL. However, HPV test was performed according to ASCP guidelines which approved routine Pap and HPV contesting for age group 30 and above. All women with HSIL have been tested positive for HR-HPV.Only 61% cases of HSL were followed up by biopsy and histology. Out of these cases 22% showed CIN2 and 67% showed CIN3. As persistence, high risk HPV is the major cause of cervical cancer and its precancerous lesions it makes sense to introduce HR-HPV testing in the management guidelines for cervical abnormalities to identify women most at risk.
The relative risk was 2.3; 95% confi dence interval (95%CI) means the event of cervical abnormalities were more seen in the HPV Positive patients as compared to the HPV negative patients. This showed a stronger association of these lesions with HPV infection. Out of HPV negative cases, most of the cases were normal, showing no cytological or histopathological problems.
Most LSIL 80% are associated with HR-risk HPV, while 20% of LSIL cases are associated with LR-HPV infection. Almost all HSIL cases and cervical cancer are associated with HR-HPV.
Only mild degree cervical abnormalities were seen in this group (LSIL) which could be related to Low risk HPV infection. No high grade cervical lesions were seen in our study in HPV negative patients. The fi ndings of association of high risk HPV with precursor cervical lesions for cervical cancer are consistent with Boldrini etal (2014) and others. The prevalence is low as compared to Al-Awadhi, a Kuwaiti study. 13 Confection with other STD was seen in 2 cases with history of herpes infection.
Out of HPV Positive cases, most of the patients showed disease (ASCUS, LSIL to HSIL and AGC). Total abnormal cases with HPV were 74% while 2 cases (3%) were inadequate with unsatisfactory fi ndings and even with our neighbor country Saudi Arabia. [14] [15] [16] 
CONCLUSION
No High grad abnormalities were associated with Negative HVP result. The precancerous cervical abnormalities were associated with high risk HPV.
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